MedTrace Logo

Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures

NCT01210820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-05-01

Study results available
· View outcomes & findings →

Summary

The results of this trial will demonstrate that ISAK performed with the iFS™ femtosecond laser is a safe procedure.

Conditions

  • Refractive Astigmatism

Interventions

DEVICE

iFS™ Femtosecond Laser System

intrastromal arcuate cuts made with iFS™ femtosecond laser

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Principal Investigators

  • Nicholas Tarantino, OD · Abbott Medical Optics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01210820 on ClinicalTrials.gov